Communications

Despite nuclear medicine’s role in personalized medicine and the potential it offers through its diagnostic and therapeutic applications, it remains a complex discipline to explain to all stakeholders. Few people are fully aware of how this technology works. Moreover, even fewer understand the high potential of radiolabeled molecules in therapeutic applications, which may transform cancer treatment in the near future.

The Nuclear Medicine Europe Communications Working Group’s mission is to communicate all relevant information about the nuclear medicine and molecular imaging industry to stakeholders and influencers, including the European Parliament, the European Commission, EU governments, national and international pharmaceutical agencies, physicians, patient groups, and the general public. Through this working group, Nuclear Medicine Europe also provides accurate scientific information to journalists for dissemination to the press.

The working group is responsible for optimizing messages and selecting appropriate media for each communication. Content is developed in collaboration with other Nuclear Medicine Europe working groups, external consultants, and partners. The group also participates in organizing the annual Nuclear Medicine Europe Symposium.

The group supports educational activities and develops teaching materials in collaboration with assigned experts for Nuclear Medicine Europe’s communities, including patients, physicians, and decision-makers.